Skip to main content
Novartis Top Menu
  • Novartis.com
Novartis Foundation LOGO
    • About Us
      • Board of Trustees
        • Joerg Reinhardt, Ph.D.
        • Ann Aerts, M.D.
        • Dr. Jo Ivey Boufford
        • Lutz Hegemann, M.D., Ph.D.
        • John Kahan
        • Prof. Peter Piot, M.D.
      • Our Team
        • Johannes Boch
        • Cristina Haffner
        • Lucy Setian
        • Sarah Des Rosiers
        • Xavier Sutter
      • Our partners
      About Us
    • Transforming population health
      • Cardiovascular population health initiative
      • AI4BetterHearts
      • AI in health policy
        • Broadband Commission Working Group on Digital and AI in Health
        • HealthTech Dialogue Hub
        • AI4HealthyCities
      • HealthTech Innovation
        • Brazil COVID-19 response
        • AI4Leprosy
        • HealthTech Hub Africa
      Transforming Population Health
    • Urban Population Health Toolkit
      • Quality of care
      • Ensure access
      • Policy reform
      • Leverage data and digital
      • Intersectoral collaboration
      • Ensure local ownership
      Urban Population Health Toolkit
    • Past programs
      • Better Hearts Better Cities
        • Community-based Hypertension Improvement Project (ComHIP)
        • Communities for Healthy Hearts
        • KaziBantu (Healthy Schools for Healthy Communities)
      • Leprosy and malaria elimination
        • The Leprosy Alert and Response Network System (LEARNS)
        • Leprosy Post-Exposure Prophylaxis (LPEP) program
        • Malaria Targeted Parasite Elimination Strategy
      • Digital Health
        • Ghana Telemedicine
        • Telemedicine Toolkit
        • Integrated e-Diagnostic Approach
      Past Programs
    • Media Center
      • News Archive
      • Media Library
      • Stories
      Media Center
    Homepage

Partnerships

  • Leprosy
    Contact tracing with prophylactic treatment could near-eliminate leprosy in a single generation, new research suggests
    LeprosyInitiativesPartnershipsGlobal Health
  • Population Health, Cardiovascular Health
    Launching AI4BetterHearts, the First Global Data Collaborative for Improving Cardiovascular Health
    Cardiovascular HealthPartnershipsData CollaborativeAIArtificial IntelligenceAnn Aerts
  • Population Health, Better Hearts Better Cities
    Novartis Foundation and Syngenta Foundation Partner to Improve Heart Health through Sustainable Agriculture and Nutrition
    Better Hearts Better CitiesCardiovascular HealthPartnersPartnerships
  • Better Hearts Better Cities
    Strategic progress and policy recommendations to enhance control and management of hypertension and cardiovascular disease in Vietnam
    Better Hearts Better CitiesHypertensionPartnerships
  • About Us, Partners
    Our Partners
    Partnerships are at the center of the Novartis Foundation's population health approach.
    PartnershipsPartners
  • Population Health, Cardiovascular Health
    Better Hearts Better Cities
    This initiative convened multisector partners to improve cardiovascular health in low-income urban populations.
    Cardiovascular HealthBetter Hearts Better CitiesHypertensionPartnerships
  • Population Health, Artificial Intelligence
    Brazil COVID-19 Response
    AI platform in São Paulo, Brazil helps diagnose COVID-19 patients faster
    COVID-19PartnershipsPartners
  • Disease Elimination, Leprosy
    Novartis Foundation Leprosy Program Wins Eyeforpharma Most Valuable Collaboration Award 2019
    Novartis Foundation leprosy program wins eyeforpharma Most Valuable Collaboration Award 2019.
    LeprosyPartnerships

Novartis Foundation

Navigate Novartis Foundation
  • About Us
  • Transforming Population Health
  • Urban Population Health Toolkit
  • Past Programs
About the Novartis Foundation
  • Board of Trustees
  • Our Partners
  • Our Team
Media Center
  • News Archive
  • Media Library
  • Our Stories
Footer Bottom
© 2022 Novartis Foundation
  • Terms of Use
  • Privacy Policy
  • Cookie Settings
  • Site Map
Novartis Site Directory
This site is intended for a global audience